The linings of the gastrointestinal tract rapidly regenerate and the balance between growth control, cell migration and differentiation needs to be tightly controlled. Our studies have identified Protein Tyrosine Kinase 6 (PTK6) as a regulator of growth and differentiation in the intestinal epithelium. PTK6 promotes normal intestinal epithelial cell differentiation in animal models. Our preliminary data indicate that knockdown of PTK6 promotes the epithelial mesenchymal transition (EMT) in human colon tumor cell lines, suggesting that PTK6 is important for maintenance of the epithelial phenotype in colon tumor cells. However in some cases, PTK6 appears to have oncogenic functions;we recently demonstrated that disruption of the Ptk6 gene in the mouse conferred resistance to carcinogen induced colon tumorigenesis, and impaired activation of the STAT3 transcription factor. We hypothesize that PTK6 plays an essential role in maintaining the epithelial phenotype, and while loss of PTK6 may impair colon tumor initiation, reduced PTK6 expression may also facilitate the EMT and promote metastases of colon tumors at later stages. To test this, we propose the following four specific aims:
Aim 1) To determine the role of PTK6 in regulating the EMT in different human colorectal tumor cell lines;
Aim 2) To examine mechanisms by which PTK6 regulates the EMT. A number of identified PTK6 substrates including Sam68, AKT, ?-catenin, and STAT3 have been implicated in the regulation of the EMT;
Aim 3) To determine the effect that PTK6 expression, activity, and intracellular localization has on metastasis of colorectal cancer cells in xenograft models in vivo;
and Aim 4) To determine how PTK6 expression correlates with the EMT and metastases in human colorectal tumors. Completion of these aims will provide a comprehensive understanding of the contributions of PTK6 to EMT signaling and colon tumor progression. Colon cancer becomes deadly after it metastasizes. Understanding the functions of PTK6 in the normal colon and in colon cancer initiation and progression will be critical for evaluating its potential as a therapeuic target.

Public Health Relevance

PTK6 is a tyrosine kinase that is expressed in the gastrointestinal tract where it regulates normal growth and differentiation, but recent studies indicate that it also contributes to colon tumorigenesis. Colon cancers become deadly after they undergo the epithelial mesenchymal transition (EMT) and metastasize, and the goal of this study is to understand functions of PTK6 in maintaining the epithelial phenotype of colon tumor cells. The proposed studies will clarify the roles for PTK6 in regulating the EMT and colon tumor metastases, and will allow us to determine if PTK6 should be targeted in colon cancer.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Clinical, Integrative and Molecular Gastroenterology Study Section (CIMG)
Program Officer
Hamilton, Frank A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Illinois at Chicago
Schools of Medicine
United States
Zip Code
Peng, Maoyu; Emmadi, Rajyasree; Wang, Zebin et al. (2014) PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors. Oncotarget 5:6038-48
Zheng, Yu; Wang, Zebin; Bie, Wenjun et al. (2013) PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer. Cancer Res 73:5426-37
Zheng, Yu; Tyner, Angela L (2013) Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer. Eur J Clin Invest 43:397-404
Zheng, Y; Gierut, J; Wang, Z et al. (2013) Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT. Oncogene 32:4304-12
Gierut, Jessica; Zheng, Yu; Bie, Wenjun et al. (2011) Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane. Gastroenterology 141:1371-80, 1380.e1-2
Brauer, Patrick M; Tyner, Angela L (2010) Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK. Biochim Biophys Acta 1806:66-73
Palka-Hamblin, Helena L; Gierut, Jessica J; Bie, Wenjun et al. (2010) Identification of beta-catenin as a target of the intracellular tyrosine kinase PTK6. J Cell Sci 123:236-45
Brauer, Patrick M; Tyner, Angela L (2009) RAKing in AKT: a tumor suppressor function for the intracellular tyrosine kinase FRK. Cell Cycle 8:2728-32
Carroll, Robert E; Goodlad, Robert A; Poole, Aleksandra J et al. (2009) Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats. Growth Horm IGF Res 19:447-56
Haegebarth, Andrea; Perekatt, Ansu O; Bie, Wenjun et al. (2009) Induction of protein tyrosine kinase 6 in mouse intestinal crypt epithelial cells promotes DNA damage-induced apoptosis. Gastroenterology 137:945-54

Showing the most recent 10 out of 19 publications